Annual Cost Of Goods Sold
N/A
December 1, 2024
Summary
- TBPH annual cost of goods sold is not available.
Performance
TBPH Cost Of Goods Sold Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Cost Of Goods Sold
N/A
December 1, 2024
Summary
- TBPH quarterly cost of goods sold is not available.
Performance
TBPH Quarterly Cost Of Goods Sold Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM Cost Of Goods Sold
N/A
December 1, 2024
Summary
- TBPH TTM cost of goods sold is not available.
Performance
TBPH TTM Cost Of Goods Sold Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Cost Of Goods Sold Formula
COGS = Beginning Inventory + Purchases − Ending Inventory
TBPH Cost Of Goods Sold Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | - | - | - |
3 y3 years | - | - | - |
5 y5 years | - | - | - |
TBPH Cost Of Goods Sold Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | ||||||
5 y | 5-year | ||||||
alltime | all time |
Theravance Biopharma Cost Of Goods Sold History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2018 | $715.00 K(-88.1%) | $632.00 K(-10.4%) | $715.00 K(-77.6%) |
Sep 2018 | - | $705.00 K(-148.7%) | $3.20 M(-8.0%) |
Jun 2018 | - | -$1.45 M(-275.3%) | $3.48 M(-44.7%) |
Mar 2018 | - | $826.00 K(-73.5%) | $6.29 M(+4.3%) |
Dec 2017 | $6.03 M(+108.4%) | $3.12 M(+216.3%) | $6.03 M(+48.5%) |
Sep 2017 | - | $985.00 K(-27.8%) | $4.06 M(+19.2%) |
Jun 2017 | - | $1.36 M(+141.4%) | $3.41 M(+27.1%) |
Mar 2017 | - | $565.00 K(-50.7%) | $2.68 M(-7.4%) |
Dec 2016 | $2.89 M | $1.15 M(+245.2%) | $2.89 M(-41.5%) |
Sep 2016 | - | $332.00 K(-48.0%) | $4.95 M(-4.8%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Jun 2016 | - | $638.00 K(-18.0%) | $5.20 M(+2.6%) |
Mar 2016 | - | $778.00 K(-75.7%) | $5.07 M(+8.7%) |
Dec 2015 | $4.66 M(+14.8%) | $3.20 M(+450.9%) | $4.66 M(-0.4%) |
Sep 2015 | - | $581.00 K(+15.0%) | $4.68 M(+4.7%) |
Jun 2015 | - | $505.00 K(+36.1%) | $4.47 M(+5.3%) |
Mar 2015 | - | $371.00 K(-88.5%) | $4.24 M(+4.5%) |
Dec 2014 | $4.06 M | $3.22 M(+773.2%) | $4.06 M(+385.4%) |
Sep 2014 | - | $369.00 K(+32.3%) | $836.00 K(+79.0%) |
Jun 2014 | - | $279.00 K(+48.4%) | $467.00 K(+148.4%) |
Mar 2014 | - | $188.00 K | $188.00 K |
FAQ
- What is the all time high annual cost of goods sold for Theravance Biopharma?
- What is the all time high quarterly cost of goods sold for Theravance Biopharma?
- What is the all time high TTM cost of goods sold for Theravance Biopharma?
What is the all time high annual cost of goods sold for Theravance Biopharma?
Theravance Biopharma all-time high annual cost of goods sold is $6.03 M
What is the all time high quarterly cost of goods sold for Theravance Biopharma?
Theravance Biopharma all-time high quarterly cost of goods sold is $3.22 M
What is the all time high TTM cost of goods sold for Theravance Biopharma?
Theravance Biopharma all-time high TTM cost of goods sold is $6.29 M